Call to arrange a consultation

Mary McMillan

Counsel

Mary McMillan has practiced exclusively in the area of intellectual property law. Mary’s practice is focused on patent related matters, with a particular emphasis on pharmaceutical, biotechnological and chemical matters. In particular, her practice focuses on patent litigation support and patent infringement and validity opinions in the pharmaceutical area including proceedings under the Patented Medicines (Notice of Compliance) proceedings. Mary also has experience in patent drafting and prosecution and freedom to operate analysis.

‍

Education

B.Sc., University of Ottawa
B.A.Sc., University of Ottawa
LL.B., University of Ottawa

‍

Bar Admission

Ontario, 1994

‍

My recent cases

Hospira Healthcare Corporation et al. v The Kennedy Institute of Rheumatology

Application for leave to appeal to the Supreme Court of Canada in a patent impeachment action relating to Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.

Statutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.

Interlocutory appeal in a patent impeachment action regarding Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation et al. v Kennedy Trust for Rheumatology Research et al.

Appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation v Kennedy Trust for Rheumatology Research

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation v Kennedy Trust for Rheumatology Research

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation v Kennedy Institute of Rheumatology

Interlocutory appeal in a patent impeachment case regarding Patent No. 2,261,630 (infliximab)

Hospira Healthcare Corporation v The Kennedy Institute of Rheumatology

Patent impeachement and patent infringement case regarding Patent No. 2,261,630 (infliximab).

Fournier Pharma Inc. et al. v Minister of Health et al.

Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent Nos. 2,372,576 and 2,219,475 (fenofibrate)

Fournier Pharma Inc. et al. v Minister of Health et al.

Application under subsection 6(1) of the old Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,487,054 (fenofibrate)